HIV Infection

Clinical guidelines vary for how often HIV-positive patients should be monitored, and several monitoring strategies exist. Researchers compared these strategies and their effects on patients in a recent...

Multiple phase 3 HIV trials suggest fixed-dose combination treatment regimens containing Gilead's investigational agent bictegravir are noninferior to those containing GlaxoSmithKline’s Tivicay.

A new study examines the possible impact of early ART exposure on renal and bone health in young adults with HIV.

After successful results from a pivotal clinical trial, a new dosage for an integrase inhibitor was approved by the FDA.

A recent study found that adapting a National HIV/AIDS Strategy for adolescents and young adults helped improve coordination of federal resources and use of best-practice models to decrease service...

Despite treatment with antiretroviral therapy, a significant proportion of new HIV cases diagnosed each year are attributed to infected semen. A new study, presented at the American Urological Association...

A recent poster presentation at the AMCP 2017 Annual Meeting showed that reducing HIV pill regimens to 2 or 3 pills could improve adherence and treatment in the United States.

Researchers investigated the influence of a positive affect intervention on psychological health and physical health of individuals with newly diagnosed HIV.

The ECDC and the WHO Regional Office for Europe released a new surveillance report on the incidence of tuberculosis in Europe.

Data from two clinical trials support recent guideline recommendations for the use of tenofovir alafenamide-based regimens in patients with HIV.